Best & Worst
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.EMI Group shares rose 23 per cent after the company said it was in talks that may signal a bidding war for the U.K.'s largest music company. EMI, producer and retailer of recordings by the Spice Girls, the Rolling Stones and other artists, didn't disclose the names of potential bidders. The company has been in talks to be acquired by Montreal-based Seagram for as much as US$9bn since January, and the discussions intensified last week. There was speculation it was also in talks with Kirk Kerkorian's Tracinda Corp and other bidders. "It could be the start of a nice little bidding war," said Lawrence Peterman at Kyte Securities.
Nycomed Amersham shares slipped 3 per cent to a 52-week low of 1,916 pence last week on worries about US competition and the possibility that it may be dropped from the FT- SE 100 index after only six months. Shares in the drugs and medical products maker have shot up by 55 per cent in the last year after the merger of Amersham International and Nycomed ASA of Norway and the formation of a major joint venture with Pharmacia & Upjohn in biotechnology instruments.
Paul Diggle at SG Securities said that while the company gained major economies of scale, especially in the US market for X-ray diagnostic supplies, it is also facing serious competition from firms like Mallinckrodt.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments